
|
|
From Discovery To Application:Scientific ProgramWednesday, February 1, 2006
5:00 - 7:00 pm Registration
7:00 - 8:30 pm Welcome Reception Exhibit Hall
Thursday, February 2, 2006
7:15 am Breakfast
8:15 am Opening Remarks George Demetri and Joanthan Fletcher
Session I - Human Cancer Biology: Target Identification
8:30 am Cancer Genome Project Todd Golub
9:15 am Discovering Signaling Targets and Identifying Biomarkers in Cancer: A Proteomic Approach Akhilesh Pandey
10:00 am Bioinformatics, Mapping Oncogenic Pathways John Chant
10:45 am Break Exhibit Hall
Session II - Drug Discovery, Screening, Development
11:00 am Relating Genotype to Phenotype with Small Molecules Stuart Schreiber
11:45 am Drugs and Discovery in Cancer Angiogenesis: VEGF Trap, VelociGene and VelocImmune George Yancopoulos
12:30 pm Lunch
Session III - Diagnostics, Biomarkers, Validation
1:30 pm Pathology Validations: Fact and Fiction Brian Rubin
2:15 pm Integrating Pathology in Drug Development Jeffrey Ross
3:00 pm Break Exhibit Hall
3:30 pm Antiangiogenic Therapies John Heymach
4:15 pm Shp2 and Its Binding Proteins in Cancer Biology Benjamin Neel
5:00 pm Presentation of Nancy Ann Hughes Welsh Young Investigator Award Thomas James Hughes
5:30 pm Poster Reception
6:30 pm Dinner and Keynote Address: From Molecular to Modular Cell Biology Webster Cavenee
Friday, February 3, 2006
7:00 am Breakfas Exhibit Hall
Session IV - Stem Cell Biology and Therapeutics
8:00 am Origins of Cancer Stem Cells Leonard Zon
8:45 am Cancer Stem Cells, Drug Resistance and New Therapies Michael Dean
9:30 am Stem Cells to Therapeutic Targets in Breast Cancer Matthew Smalley
10:15 am Break
Session V - Clinical Development
10:45 am Successes and Failures in Drug Development: Lessons from History Ben Askew
11:30 am EGFR Mutants: Biology and Therapeutic Opportunities Daniel Haber
12:15 pm Cancer Drug Development and Somatic Genetic Alterations William Sellers
1:00 pm Closing Remarks
1:15 pm Adjourn |
|